Abstract Dendritic cells (DCs) sense the presence of pathogens through germline-encoded pattern recognition receptors (PRRs), which recognize molecular patterns expressed by various microorganisms and endogenous stimuli. Toll-like receptors (TLRs) are the best characterized PRRs. TLR activation has a profound effect on a number of DC activities, including endocytosis, cytoskeleton rearrangement, migration, antigen processing and presentation, survival, and death. The goal of TLRinduced DC reprogramming is to promote the appropriate activation and differentiation of lymphocytes bearing clonally distributed antigen-specific receptors. In this review, we will focus on the functional consequences of TLR engagement for conventional DCs.
Introduction
Dendritic cells (DCs) were first described by R. Steinman and Z. Cohn in 1973 [1] . These authors subdivided phagocytes into macrophages and DCs on the basis of their effector functions: antimicrobial and scavenging functions for macrophages and professional antigen presentation for DCs. DCs have since been characterized in great detail and the molecular basis of the regulation of their functional properties has been determined. DCs are located in lymphoid and nonlymphoid organs and are quiescent until they encounter inflammatory exogenous or endogenous stimuli. They use a repertoire of innate nonclonal receptors to perceive the different types of stimuli and to transduce this information within the cell. Toll-like receptors (TLRs) are the best characterized of these receptors. Following interaction with inflammatory stimuli, DCs undergo complex transcriptional reprogramming, involving the differential expression of thousands of genes and the integration of a number of signaling pathways. The active transcriptional response results in the acquisition by DCs of various functional properties relating to activation of the appropriate immune responses. In particular, after exposure to inflammatory stimuli, DCs lose their ability to take up antigens, become extremely efficient at antigen processing and acquire the ability to migrate to the T-cell areas of secondary lymphoid organs, where they present antigens to naive T cells to initiate primary adaptive responses. Finally, after achieving their effector functions, DCs undergo terminal differentiation and die by apoptosis [2] .
In this mini-review, we will focus on the changes in activities, such as endocytosis, cytoskeleton rearrangement, migration, antigen processing and presentation, survival, and death induced by TLR stimulation in a subpopulation of DCs known as conventional DCs. Since much attention has already been given to the effect of TLR stimulation on costimulatory molecule and cytokine expression by DCs, we refer the readers to other review articles for an extensive and comprehensive description of the subject [3] [4] [5] [6] .
DC classification
DCs are highly heterogeneous, their characteristics depending on their origin and location. Two main classes of DCs have been described: conventional and pre-DCs. At the steady state, conventional DCs (cDCs) display all the typical phenotypic and functional characteristics that have been originally used to describe DCs. Indeed, they are veiled cells of myeloid origin capable of efficiently processing and presenting antigens and of priming naive T cells. By contrast, pre-DCs must undergo an additional differentiation step, induced by inflammatory stimuli (microbial and endogenous stimuli that activate TLRs) in most cases, to acquire the characteristics of DCs, including the efficient antigen-presenting capacity. Plasmacytoid DCs (pDCs) and monocytes are classified as pre-DCs, as both can further differentiate into efficient antigen-presenting cells (APCs) in the presence of microbial stimuli [7] . Conventional DCs may also be subdivided into migratory and lymphoid tissue-resident DCs. Migratory cDCs reside in nonlymphoid tissues where they continuously scan the environment to detect the presence of invading microorganism. Upon microbial encounter tissue-resident migratory cDCs migrate to the draining lymph nodes through the afferent lymphatic vessels.
Lymphoid tissue-resident cDCs are not present in the afferent lymphatic system and encounter the antigen directly inside the lymphoid organs. Antigens can reach the lymphoid organs through the blood, by freely migrating through the lymphatics or associated to migratory cDCs. Most thymic and splenic DCs and about half the lymph node DCs are lymphoid tissue-resident cells [7] .
cDCs have been in turn subdivided into different subtypes. The number of subtypes is continuously growing. Subset classification is based on tissue origin and the expression of particular markers for migratory cDCs, and on marker expression for lymphoid tissueresident DCs [8] [9] [10] [11] .
TLR expression by DCs
The inflammatory stimuli sensed by DCs may be exogenous, such as microbial structures (pathogen-associated molecular patterns), or endogenous, such as heat shock proteins, hyaluronate and heparan sulfate (extracellular matrix breakdown products), fibronectin, high mobility group box 1 protein, and modified low-density lipoproteins [12] . DCs perceive these stimuli through germline-encoded pattern recognition receptors (PRRs) [13] , which constitute a large superfamily of receptors located at the cell surface, in the endosomal compartment, and in the cytosol (Fig. 1a) .
TLRs are the best characterized PRRs. So far, 13 different TLRs have been identified. TLRs 1-9 are conserved in humans and mice, TLR10 is expressed only in humans and TLR11 is functional in mice [14] . Although a lot of information is available concerning the functional activities of TLRs 1-9 and 11, basic knowledge on the physiology of TLRs 10, 12, and 13, is still lacking [15] . TLRs 1-6 and 11 are expressed at the cell surface and can be activated by molecules generally located at the surface of bacteria, fungi, or protozoa. TLR 3, 7, 8, and 9 are located in the endoplasmic reticulum and recognize microbial nucleic acids [15] . Different DC classes express different groups of TLRs, defining their specific roles in innate and, ultimately, adaptive immune responses. In humans, pDCs express TLR7 and 9 and cDCs express TLR1-6, 8, and 10 [16] [17] [18] [19] [20] (Fig. 1b) . In mice, TLR expression by DCs is less restricted, with cDCs expressing all TLRs. The only exception to this rule is TLR7, which is not expressed by CD8α + spleen cDCs in mice [21] . As in humans, mouse pDCs have high levels of TLR7 and 9, but, unlike human pDCs, these cells produce mRNAs for all TLRs, with the possible exception of TLR3 [21] . No information is available concerning possible differences in TLR expression by cDC subtypes.
Following interaction with their agonists, TLRs initiate different signaling pathways that lead to the activation of specific transcription factors such as nuclear factor-κB (NF-κB) and activator protein-1 (AP-1). This is independent of the nature of the microbial stimulus. All TLR family members, except from TLR3, induce the activation of NF-κB and AP-1 by recruiting the adaptor myeloid differentiation primary response gene 88 (MyD88). Diversely, TLR3 transduces the signal via the adaptor TIR-domain containing adaptor-inducing IFN-beta (TRIF) [22] . Whereas the activation of NF-κB and AP-1 is a common feature of the signaling induced by all TLRs, only a subset of them is additionally able to trigger the activation of the transcription factors interferon regulatory factor 3 (IRF3) and IRF7 which largely regulate the expression of type I IFNs [23] . Type I IFN induction is TRIF-dependent for TLR3, whereas it is MyD88-dependent for TLR2, TLR7, TLR8, and TLR9 [24] [25] [26] [27] [28] [29] .
A notable exception is represented by TLR4, which recruits both MyD88 and TRIF to induce the activation of NF-κB and AP-1 and, similarly to TLR3, it recruits TRIF to stimulate the production of type I IFNs though in response to non-nucleic acid ligands. Compartimentalization is an important aspect of TLR signaling. While the MyD88 pathway can start both from the membrane and the endosome, the TRIF pathway always starts from the endosome as well as the signaling pathway that leads to type I IFN production [30] .
TLR-mediated regulation of cDC functions
TLR engagement on cDCs leads to a coordinated transcriptional response involving thousands of genes. The active transcriptional response modulates various activities, but as previously stated we will focus our attention on [2, 31] endocytosis, cytoskeleton rearrangements, migration and antigen processing, and presentation. This process is generally called DC maturation.
Antigen uptake
In the first few hours after activation with lipopolysaccharide (LPS), murine cDCs derived from bone marrow or purified from the spleen and human monocyte-derived DCs display a transient increase in the efficiency of their endocytic and phagocytic activities [32] . It has been hypothesized that this process is presumably required to maximize antigen uptake at the start of infection [33] , to optimize subsequent antigen presentation and the activation of adaptive immune responses. This increase in the efficiency of endocytosis is strictly dependent on extracellular signal-regulated kinase 1/2 (ERK1/2) and p38α mitogen-activated protein kinase and coincides with the transient disassembly of actin-rich podosomes [32] . However, the molecular mechanism regulating DC endocytosis following TLR engagement has not been investigated.
The endocytic function of cDCs is then gradually lost as they acquire the ability to migrate [33], a property strictly dependent on podosome formation, which is regulated by ADP-ribosylation factor 6 during maturation [34] . Antigen capture and migration therefore seem to be mutually exclusive activities of cDCs, both highly dependent on cytoskeleton organization.
Cytoskeleton rearrangements and migration TLR signaling guides actin cytoskeleton rearrangements. Immature mouse spleen cDCs are slightly adherent, with well-organized actin cables. A few hours after LPS treatment, they become strongly adherent, with some veils and actin cables visible. They then become polarized, with lamellipodia and retraction fibers. Fully mature cDCs are nonadherent, round cells with an actin cytoskeleton organized into a punctate distribution [35] . The molecular mechanism inducing actin cytoskeleton modifications is largely unknown. Currently, only two molecules have been directly associated with this process such as the MARCO receptor in mouse spleen cDCs and the actin-bundling protein fascin, both of which are induced during maturation [35] [36] [37] . The polarization of cDCs after activation indicates that the cells have acquired the ability to migrate. They then migrate to lymph nodes, and spleen marginal zone cDCs begin to mobilize to the T-cell zone. The cells reaching the T-cell zone in the lymph nodes and spleen have the most suitable phenotype for T-cell activation [7] . Migration to the T-cell areas of the lymph nodes and spleen is regulated by CCR7 expression [38, 39] , rendering cDCs responsive to CCL19 and CCL21. In the absence of CCR7, the migratory cDCs fail to reach the lymph nodes, and DCs within the spleen are mostly located in the marginal zone and outside the white pulp [40, 41] .
Another molecule, the MHC class II-associated invariant chain or CD74, has been associated with the regulation of cDC migration in mice [42] . LPS-activated, CCR7-expressing cDCs move faster in the absence of CD74. Thus, consistent with the hypothesis that antigen uptake and migration are jointly regulated processes ensuring the efficient detection and uptake of the antigen by cDCs in a defined space before migration to the lymphoid organs, antigen processing, and migration seem to be subjected to coordinated regulation [42] .
Antigen processing
The endocytic activity of cDCs is finalized to antigen processing and presentation and not to bacterial clearance, process in which cDCs are very inefficient [43] . The much lower efficiency of antigen degradation of DCs compared to macrophages and neutrophils is, at least in part, due to the lower concentration of proteases in the phagosomes. Indeed, although cDCs produce lysosomal proteases, they are not efficiently recruited to the phagosomes. Moreover, cDCs produce multiple cystatine protease inhibitors that inhibit the lytic activity of lysosomes and phagosomes [44, 45] .
Following TLR activation the efficiency of antigen processing for class I and class II presentation by cDCs strongly increase. The maximization of the efficiency of different steps of the processing pathway accounts for this final effect. Initially, there is an upregulation of surface class I and II expression. Class I molecules are synthesized de novo while class II molecules, normally stored inside the cells, are massively transported at the cell membrane. Secondly, peptide-MHC complexes are stabilized at the cell surface, otherwise being rapidly internalized and recycled [46] [47] [48] . Lastly, peptide generation for both class I and class II presentation increases in intensity. Indeed, the proteasome efficiency augments thanks to a change of its protease composition [49, 50] and, similarly, lysosomal function increases in efficiency by the increase of acidification [51] .
It is important to note that cDCs can distinguish between antigens bearing or not TLR ligands. When antigencontaining particles, either free or conjugated with LPS, are subjected to phagocytosis by cDCs, antigens taken up with LPS are preferentially presented. Thus, TLRs can control the generation of T-cell receptor ligands, ensuring the preferential presentation of microbial antigens over selfantigens during the infection process [52] . The molecular mechanism of this surprising phenomenon has not been elucidated so far.
Another interesting aspect of the class II processing machinery is the retention of internalized antigens in a mildly acidic storage compartment [53] , antigen processing occurring only after the fusion of the storage vesicles with the lysosomes. It has been proposed that the delay of antigen processing would be important to guarantee presentation of antigens on class II long after activation also considering the high stability of class II molecules in activated cDCs [48] .
Conventional DCs can present exogenous antigens on MHC class I molecules, in a process known as crosspresentation [54] . The efficiency of cross-presentation and of CD8 + T-cell cross-priming is greater if the antigen is taken up together with TLR agonists [55] .
Once activated by inflammatory stimuli, via the TLRs, cDCs display an upregulation not only of class I and class II molecules, but also of costimulatory molecules, and acquire the ability to secrete inflammatory cytokines. Thus, on arrival in the T-cell area of the lymph nodes and spleen, these cells are already specialized for the activation of T-cell responses.
TLR-mediated regulation of cDC survival and death
In addition to regulating cDC functions, TLR engagement also regulates cDC survival and apoptotic death. An initial increase in cDC survival immediately after activation is necessary to promote T-cell priming. However, the activated cDCs must then have a limited lifespan, to regulate the availability of antigens for T cells, to control immune responses, and to prevent autoimmunity.
The survival of cDCs after TLR-mediated activation is regulated by the antiapoptotic factor Bcl-xL. TLR9 engagement inhibits spontaneous cDC apoptosis following growth factor withdrawal, by upregulating cellular inhibitor of apoptosis proteins (cIAPs), Bcl-2, and Bcl-xL and by downregulating active caspase 3. The upregulation of cIAPs and the downregulation of active caspase-3 require PI3K activation [56] . The LPS-induced rescue of cDCs from immediate apoptosis after the withdrawal of growth factors is dependent on the activation of ERK [57] .
Once cDCs have completed their antigen presentation function in the T-cell area of the lymph node and spleen, they are eliminated by apoptosis, thereby damping responses and liberating the space occupied by these cells after migration [58] . The molecular mechanism leading to cDC apoptosis after exposure to the smooth form LPS has recently been partially dissected. The receptor complex of smooth LPS is represented by a series of proteins, including LPS binding protein (LBP), TLR4, MD2, and CD14. The soluble protein, LBP, binds aggregates or bacterial membranes micellae of LPS and facilitates its recognition by CD14 by the extraction of monomer forms. Subsequently, CD14, a glycosylphosphatidylinositol-anchored receptor, transfers LPS to the TLR4-MD-2 complex. Finally, thanks to the essential role of MD-2 in inducing TLR4 dimerization [59] , the MyD88-dependent and independent transduction pathways initiate.
We have recently shown that after stimulation with smooth LPS, CD14 can induce a transduction pathway leading to src kinases and phospholipase c (PLC)γ2 activation, increase in intracellular Ca 2+ concentration and the translocation to the nucleus of calcineurin-dependent nuclear factor of activated T cells (NFAT). The activation of this pathway is totally independent of TLR4 and other TLRs. The translocation of the NFATc2 and c3 isoforms to the nucleus is required for cDC terminal differentiation and apoptotic death. NFAT deficiency in cDCs blocks the apoptotic pathway, increasing the efficiency of antigenspecific T-cell activation [60] . At the moment, it remains unclear how the c2 and c3 NFAT isoforms regulate the apoptotic death of cDCs. In addition, it remains to be determined whether CD14 induces Ca 2+ fluxes directly or indirectly. There are two possibilities: either CD14 directly induces Ca 2+ mobilization through interactions with lipid rafts and src kinase activation, or CD14 presents LPS to a third protein (by analogy with LPS presentation to TLR4), which in turn induces Ca 2+ mobilization. Observations of various human diseases and experimental mouse models have highlighted the importance of reducing cDC lifespan to prevent autoimmunity. Abnormal DC homeostasis is observed in patients with autoimmune lymphoproliferative syndrome type II due to missense mutations in the caspase 10 gene. These mutations interfere with the apoptosis induced by death receptors, such as FAS and TRAIL, in particular [61] . Abnormal cDC accumulation is also observed in FAS-deficient mice, which display systemic autoimmunity, arthritis, and immune complex glomerulonephrosis. Consistent with these observations, signs of autoimmunity, such as anti-nuclear antibody production, have been found in two different experimental models in which DC apoptosis has been specifically inhibited, either by blocking caspase activation or by inducing FAS ablation exclusively in cDCs [62, 63] .
DC accumulation may result from the inhibition of apoptosis, an increase in expansion efficiency, or both. Consistent with observations described above, autoimmune disease development was observed in dendritic cell immunoreceptor (Dcir)-deficient mice, which display excessive DC expansion [64] . Dcir is a C-type lectin receptor expressed preferentially in DCs. It transduces a negative signal within the cells and prevents the differentiation of DCs from precursors. Dcir-deficient mice develop sialadenitis and enthesitis, associated with an increase in serum autoantibody levels with age. They also display an excessive response to collagen-induced arthritis [64] . Interestingly, it has been reported that single nucleotide polymorphisms in the human DCIR gene are associated with susceptibility to a particular form of rheumatoid arthritis [65] .
Thus, regulation of the cDC life cycle in both resting and inflammatory conditions is a prerequisite for the maintenance of immune system homeostasis and the prevention of autoimmunity (Fig. 2) .
Identification of the molecular pathways leading to cDC apoptosis after activation is important not only for the identification of possible intervention strategies in selected Fig. 2 Diagram showing the process of DC maturation induced by activation stimuli autoimmune diseases but also for vaccination approaches. Indeed the immune potentiator activity of adjuvants is due to PRR engagement. Although the rapid turnover of cDCs is essential for the maintenance of self-tolerance in normal physiological conditions, in vaccination strategies, the efficiency of DC effector functions, such as antigen uptake, and antigen-specific T-cell priming, may be compromised if the cDCs die too rapidly due to exposure to adjuvant. Knowledge of the pathways underlying cDC apoptosis would make specific modifications designed to increase adjuvant efficiency in vaccine formulations possible.
Conclusions
The existence of PRRs, germline-encoded nonclonal receptors recognizing microbial pathogens, was first suggested by Janeway, about 20 years ago [66] . In Janeway's vision, these innate receptors-expressed by effector cells of the innate immune system, APCs, and surface epithelial cells-would alert the immune system to the presence of a microorganism, making it possible to mount an immediate inflammatory response. Moreover, by transducing the signal of alert in professional APCs, these receptors would control the activation and differentiation of lymphocytes bearing clonal antigen-specific receptors, thereby promoting adaptive immune responses appropriate for the type of infection.
TLRs, discovered more than 10 years ago [67] , fulfill Janeway's definition of PRRs. Their activation on APCs, including DCs in particular, induces profound genetic reprogramming, enabling them to prime T-cell responses and to activate acquired immunity, by controlling the phagocytic, migratory, antigen processing, and presentation activities of DCs, as well as DC cytokine production, survival, and death.
The true specificity of TLRs for their various ligands (at both the recognition and signal transduction pathway levels) remains to be determined. Further studies are also required to investigate how this specificity is determined and how exactly and to what extent it controls the differentiation of adaptive immune responses. 
